Niemann, S.

cancer patient mutation phaeochromocytoma marker paraganglioma methylation breast panel result tumours immunohistochemistry sdhb immunohistochemistry prediction study analysis adjuvant outcome breast cancer cross-validated prediction score therapy score pitx 2 model syndrome four-marker panel germline tumour pitx 2p index c index chemotherapy testing dna methylation treatment phaeochromocytoma –paraganglioma syndrome series sample article amplificate tumor outcome prediction performance multivariate dna methylation markers survival selection tissue marker panel cross-validated t stage four-marker variable procedure node-positive fferent department germline mutations association feature node-positive breast cancer anthracycline-based research cohort protein c 20orf speci ficity stage absence multivariate model sdhb immunostaining mitochondrial feature selection cancer research tumour cells –paraganglioma table expression antibody recurrence